Wolverine Trading
CRMD icon

Wolverine Trading’s CorMedix CRMD Stock Holding History

Wolverine Trading’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-45,937
Closed -$507K – 4904
2025
Q1 		$310K Buy
45,937
+25,515
+125% +$264K ﹤0.01% 3482
2024
Q4 		$165K Sell
20,422
-24,937
-55% -$249K ﹤0.01% 4630
2024
Q3 		$365K Sell
45,359
-8,655
-16% -$46.8K ﹤0.01% 3390
2024
Q2 		$234K Buy
54,014
+40,884
+311% +$208K ﹤0.01% 3679
2024
Q1 		$55.7K Sell
13,130
-2,971
-18% -$10.3K ﹤0.01% 4198
2023
Q4 		$60.5K Buy
+16,101
New +$55.4K ﹤0.01% 4213
2023
Q3 		– Sell
-11,700
Closed -$46.1K – 4580
2023
Q2 		$46.1K Buy
+11,700
New +$57.9K ﹤0.01% 3968
2023
Q1 		– Sell
-14,971
Closed -$61.3K – 4341
2022
Q4 		$63K Sell
14,971
-8,776
-37% -$31K ﹤0.01% 3530
2022
Q3 		$67K Buy
23,747
+3,766
+19% +$15.7K ﹤0.01% 4051
2022
Q2 		$72K Buy
19,981
+5,607
+39% +$20.8K ﹤0.01% 3948
2022
Q1 		$84K Buy
+14,374
New +$65.8K ﹤0.01% 4892
2021
Q4 		– Sell
-21,781
Closed -$108K – 6026
2021
Q3 		$101K Buy
21,781
+6,339
+41% +$36.9K ﹤0.01% 5762
2021
Q2 		$110K Sell
15,442
-3,841
-20% -$30.6K ﹤0.01% 5355
2021
Q1 		$173K Buy
19,283
+2,630
+16% +$27.7K ﹤0.01% 5155
2020
Q4 		$123K Buy
+16,653
New +$113K ﹤0.01% 4408
2020
Q3 		– Sell
-27,009
Closed -$136K – 4591
2020
Q2 		$167K Buy
27,009
+6,993
+35% +$32.4K ﹤0.01% 3925
2020
Q1 		$71K Buy
20,016
+6,836
+52% +$38.6K ﹤0.01% 4150
2019
Q4 		$90K Buy
+13,180
New +$80.5K ﹤0.01% 4316

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wolverine Trading's CRMD Position: Q2 2025 in Review

Wolverine Trading sold out of CorMedix (CRMD) in Q2 2025, closing a stake of 45,937 shares — an estimated $507K sold.

Wolverine Trading first reported a position in CRMD in Q4 2019 and held it in 18 quarters. The position peaked at $365K in Q3 2024. 172 funds tracked by Wall St. Rank hold CRMD as of Q2 2025.

  • Wolverine Trading reported no remaining CorMedix position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 45,937 CorMedix shares in Q2 2025, an estimated $507K.
  • Wolverine Trading first reported a position in CorMedix in Q4 2019 and held it in 18 quarters.
  • Wolverine Trading's CorMedix position peaked at $365K in Q3 2024.
  • 172 funds tracked by Wall St. Rank held CorMedix as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.